Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians
<i>Objectives:</i> To evaluate neurologists and other clinicians' contributions to U.S. ALS diagnostic timelines. <i>Background</i>: Over the past two decades, the average time to ALS diagnosis in the U.S. has remained unchanged at 12 months. ALS patients see 3-4 clinicians prior to referral to an ALS specialist for diagnosis confirmation and/or treatment initiation. There is an urgent need to identify where delays occur, so that targeted clinician awareness may be raised about early suspicion and referrals. <i>Methods</i>: Review of Medicare claims database for health care utilization patterns by ALS beneficiaries during diagnostic journey. Survey of typical clinic wait times for new consultations reported by 75-78 ALS Certified Treatment Centers of Excellence (2019-2021). <i>Results</i>: During 2011-2021, 78,520 Medicare beneficiaries were diagnosed with ALS (T0). The mean (median) timelines between first neurologist ambulatory visit and T0, is 16.5 (11.0) months; mean ± SD for ALS/neuromuscular providers being 9.6 ± 12.6 months versus 16.7 ± 17.5 months for non-neuromuscular neurologists. During the 12-months preceding T0, an ALS patient undergoes median(max) 1.5(4.0) brain-MRIs, 1.6(6.0) spine-MRIs, and 1.3(4.0) electromyography studies. Greater than 75% of ALS centers consistently report ≤ 4 week wait times for new ALS consults. This study introduces "thinkALS," an easy-to-use clinical diagnostic and referral guide for non-ALS neurologists to tackle this challenge. <i>Conclusions:</i> This study is the first to provide metrics on how non-neuromuscular/ALS specialists contribute to ALS diagnostic timelines in the U.S.
Authors
- Terry Heiman‐Patterson (ORCID: https://orcid.org/0000-0002-9910-1041)
- Neil Thakur (ORCID: https://orcid.org/0000-0003-2099-3364)
- Daniel R. Waldo
- Ilisa Halpern Paul
- Suma Babu (ORCID: https://orcid.org/0000-0002-2648-7625)
- Björn Oskarsson (ORCID: https://orcid.org/0000-0002-1725-9866)
- Kuldip D. Dave
- Melody Schaeffer (ORCID: https://orcid.org/0000-0002-7299-9162)
- Wendy Selig (ORCID: https://orcid.org/0000-0002-9252-7170)
- Jill Yersak
- Ramona Krauss
- Catherine Lomen‐Hoerth (ORCID: https://orcid.org/0000-0003-3320-5996)
- Brittany Garcia-Trujillo
Institutions
- Harvard University (US)
- University of California, San Francisco (US)
- Temple College (US)
- WinnMed (US)
- Amyotrophic Lateral Sclerosis Association (US)
- Massachusetts General Hospital (US)
- Amplyx Pharmaceuticals (United States) (US)
- Mayo Clinic in Florida (US)
- The Stables (GB)
- Actuarial Research Corporation (US)
- Temple University (US)
Publication Details
- Journal
- Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1080/21678421.2024.2432034
- Citations
- 4
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- ALS Association